See more : Takeda Pharmaceutical Company Limited (TAK) Income Statement Analysis – Financial Results
Complete financial analysis of Ayr Wellness Inc. (AYRWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ayr Wellness Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Xref Limited (XF1.AX) Income Statement Analysis – Financial Results
- Kingboard Holdings Limited (KBDCY) Income Statement Analysis – Financial Results
- Worth Peripherals Limited (WORTH.NS) Income Statement Analysis – Financial Results
- Quantum Solar Power Corp. (QSPW) Income Statement Analysis – Financial Results
- VusionGroup (0OA4.L) Income Statement Analysis – Financial Results
Ayr Wellness Inc. (AYRWF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ayrwellness.com
About Ayr Wellness Inc.
Ayr Wellness Inc., a vertically-integrated cannabis multi-state operator, cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. The company's cannabis and cannabis products include concentrates, edibles, and vaporizer products. It also provides administrative, consulting, and operations support services to licensed cannabis companies. As of July 26, 2022, Ayr Wellness Inc. operated 49 dispensaries. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 463.63M | 465.62M | 357.61M | 155.11M | 75.20M | 722.57K |
| Cost of Revenue | 261.19M | 275.17M | 219.51M | 52.01M | 48.94M | 0.00 |
| Gross Profit | 202.44M | 190.45M | 138.10M | 103.10M | 26.26M | 722.57K |
| Gross Profit Ratio | 43.66% | 40.90% | 38.62% | 66.47% | 34.92% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 136.74M | 63.14M | 46.01M | 7.98M |
| Selling & Marketing | 0.00 | 0.00 | 7.70M | 2.15M | 1.35M | 0.00 |
| SG&A | 177.80M | 222.09M | 144.44M | 65.29M | 47.35M | 7.98M |
| Other Expenses | 61.86M | 63.21M | 84.76M | 104.93K | 202.61K | -29.25M |
| Operating Expenses | 239.66M | 278.95M | 185.10M | 83.47M | 57.65M | 7.98M |
| Cost & Expenses | 500.84M | 554.12M | 404.61M | 135.49M | 106.59M | 7.98M |
| Interest Income | 743.00K | 275.00K | 203.59K | 10.11K | 404.84K | 0.00 |
| Interest Expense | 39.40M | 30.58M | 16.55M | 4.12M | 3.04M | 0.00 |
| Depreciation & Amortization | 92.62M | 76.15M | 58.83M | 16.53M | 10.31M | 3.24M |
| EBITDA | 86.15M | -67.66M | 87.69M | 17.21M | -20.77M | 0.00 |
| EBITDA Ratio | 18.58% | 14.57% | 27.06% | 24.23% | -27.63% | 3,044.49% |
| Operating Income | -37.21M | -243.02M | -56.01M | 16.12M | -37.47M | 22.00M |
| Operating Income Ratio | -8.03% | -52.19% | -15.66% | 10.39% | -49.83% | 3,044.49% |
| Total Other Income/Expenses | -8.54M | 35.16M | 68.32M | -3.74M | -121.88M | -33.27M |
| Income Before Tax | -45.76M | -210.11M | 12.31M | -151.97M | -159.34M | -36.51M |
| Income Before Tax Ratio | -9.87% | -45.12% | 3.44% | -97.97% | -211.91% | -5,052.55% |
| Income Tax Expense | 47.39M | 45.38M | 29.26M | 24.37M | 4.84M | 29.09M |
| Net Income | -272.43M | -245.47M | -16.95M | -176.33M | -164.18M | -36.51M |
| Net Income Ratio | -58.76% | -52.72% | -4.74% | -113.68% | -218.34% | -5,052.55% |
| EPS | -3.68 | -3.58 | -0.30 | -6.32 | -9.43 | -12.36 |
| EPS Diluted | -3.68 | -3.58 | -0.30 | -6.32 | -9.43 | -12.36 |
| Weighted Avg Shares Out | 74.10M | 68.64M | 57.33M | 27.89M | 17.40M | 2.95M |
| Weighted Avg Shares Out (Dil) | 74.10M | 68.64M | 57.33M | 27.89M | 17.40M | 2.95M |
AYR Wellness Reports Fourth Quarter and Full Year 2023 Results
FY 2023 Revenue up 10% to $463.6 Million, Excluding Discontinued Operations FY 2023 GAAP Loss from Operations Improved to $37.2 Million, Excluding Discontinued Operations FY 2023 Adjusted EBITDA 1 up 51% to $114.0 Million, with Adjusted EBITDA Margin of 25%...
Cannabis stocks rise after President Biden mentions plant in State of the Union speech
Shares of both U.S. and Canadian cannabis stocks moved up on Friday after President Joe Biden mentioned the federal government's current effort to potentially reclassify the plant under federal law in his State of the Union speech.
AYR Cannabis Dispensary Celebrates Opening of Relocated Tallahassee Retail Location
MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- AYR Cannabis Dispensary , a cannabis retail chain owned by AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced the...
These 3 Marijuana Stocks to Buy Could Be The Ones You Want
Marijuana stock investors are keeping hopes high in 2024. There is a lot to be seen and done yet some things have started to take action. 2024 is an election year for the United States. What this means is some...
It's Time! 3 Overhyped Cannabis Stocks to Sell in February.
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ) has surged by nearly 30% year-to-date, showcasing the rejuvenated demand for cannabis stocks. Salient to the ETF's year-to-date performance has been the increased popularity of high-beta securities.
CSE Bulletin: New Listing - Ayr Wellness Inc. 7FEB2026 Warrants (AYR.WT.U)
Toronto, Ontario--(Newsfile Corp. - le 12 février/February 2024) - Ayr Wellness Inc. 7FEB2026 Warrants have been approved for listing. Each Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the Issue Date and prior to the Expiry...
AYR Wellness to Hold Fourth Quarter and Full Year 2023 Conference Call on March 13 at 8:30 a.m. ET
MIAMI, Feb. 08, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, will hold a conference call on Wednesday, March 13, 2024, at 8:30 a.m. ET...
AYR Completes Previously Announced Plan of Arrangement
MIAMI, Feb. 07, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, is pleased to announce that it has successfully completed its previously announced court-approved plan...
The Best Marijuana Stocks To Start The Week
Marijuana stock investors are watching the sector with the idea that momentum will build even more. With a continuous battle to establish better reform, more people are looking to invest. The future of the cannabis industry is moving at a...
Top Marijuana Stocks For You 2024
If you are a marijuana stock investor there is much to look forward to that could help how the sector performs. For some time now the cannabis sector has displayed high levels of volatile trading. Much of this is due...
Source: https://incomestatements.info
Category: Stock Reports